Search

everythinglearnresearchcommunity

for

Search:↓

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Baricitinib is a promising treatment for alopecia areata.

A genetic mutation in the EDA gene causes hypohidrotic ectodermal dysplasia in cats.

Defective protein folding due to a mutation is key in ANE syndrome.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Atg5 can promote tumors when autophagy is deficient but suppresses them under normal conditions.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

The Eda gene helps regulate the hair cycle in goats.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

COX2 and ATP synthase control the size of hedgehog spines.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.